Quest Diagnostics (DGX)
NYSE: DGX
· Real-Time Price · USD
179.52
-1.44 (-0.80%)
At close: Oct 03, 2025, 3:59 PM
181.31
1.00%
After-hours: Oct 03, 2025, 06:22 PM EDT
-0.80% (1D)
| Bid | 176.54 |
| Market Cap | 20.07B |
| Revenue (ttm) | 10.52B |
| Net Income (ttm) | 949M |
| EPS (ttm) | 8.34 |
| PE Ratio (ttm) | 21.53 |
| Forward PE | 17.49 |
| Analyst | Hold |
| Dividends | $3.9 |
| Ask | 181.31 |
| Volume | 1,172,636 |
| Avg. Volume (20D) | 986,155 |
| Open | 179.94 |
| Previous Close | 180.96 |
| Day's Range | 178.25 - 180.68 |
| 52-Week Range | 146.17 - 191.49 |
| Beta | 0.56 |
| Ex-Dividend Date | Oct 3, 2025 |
Analyst Forecast
According to 0 analyst ratings, the average rating for DGX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsQuest Diagnostics is scheduled to release its earnings on
Oct 21, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 months ago
+6.78%
Quest Diagnostics shares are trading higher follow...
Unlock content with
Pro Subscription
6 months ago
-2.57%
Quest Diagnostics shares are trading lower after the company issued Q1 revenue and EPS guidance below estimates.
2 weeks ago · businesswire.com
WHOOP to Bring Clinical Lab Testing from Quest Diagnostics to the WHOOP AppBOSTON--(BUSINESS WIRE)--WHOOP, the human performance company, today announced that Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, will be the U.S. lab provider ...
